Literature DB >> 24561520

Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23).

E A Coenen1, C M Zwaan2, J Stary3, A Baruchel4, V de Haas5, R W Stam1, D Reinhardt6, G J L Kaspers7, S T C J M Arentsen-Peters1, C Meyer8, R Marschalek8, L L Nigro9, M Dworzak10, R Pieters2, M M van den Heuvel-Eibrink2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24561520     DOI： 10.1038/leu.2014.82

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  22 in total

1.  Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins.

Authors:  K Fujimoto; M Shen; M Noshiro; K Matsubara; S Shingu; K Honda; E Yoshida; K Suardita; Y Matsuda; Y Kato
Journal:  Biochem Biophys Res Commun       Date:  2001-01-12       Impact factor: 3.575

2.  High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).

Authors:  Jenny E Kuipers; Eva A Coenen; Brian V Balgobind; Jan Stary; Andre Baruchel; Valerie de Haas; Eveline S J M de Bont; Dirk Reinhardt; Gertjan J L Kaspers; Jacqueline Cloos; Astrid A Danen-van Oorschot; Monique L den Boer; Rolf Marschalek; Claus Meyer; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

3.  DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence.

Authors:  Yingjuan Qian; Jin Zhang; Bingfang Yan; Xinbin Chen
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

4.  Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells.

Authors:  Yunyan Wu; Fuyuki Sato; Ujjal Kumar Bhawal; Takeshi Kawamoto; Katsumi Fujimoto; Mitsuhide Noshiro; Satoko Morohashi; Yukio Kato; Hiroshi Kijima
Journal:  Int J Mol Med       Date:  2011-02-14       Impact factor: 4.101

5.  Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2.

Authors:  H Nakamura; K Tanimoto; K Hiyama; M Yunokawa; T Kawamoto; Y Kato; K Yoshiga; L Poellinger; E Hiyama; M Nishiyama
Journal:  Oncogene       Date:  2008-03-17       Impact factor: 9.867

6.  A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation.

Authors:  Takeshi Kawamoto; Mitsuhide Noshiro; Fuyuki Sato; Koji Maemura; Norihiko Takeda; Ryozo Nagai; Tomoyuki Iwata; Katsumi Fujimoto; Masae Furukawa; Kazuko Miyazaki; Sato Honma; Ken ichi Honma; Yukio Kato
Journal:  Biochem Biophys Res Commun       Date:  2004-01-02       Impact factor: 3.575

7.  New genes involved in cancer identified by retroviral tagging.

Authors:  Takeshi Suzuki; Haifa Shen; Keiko Akagi; Herbert C Morse; James D Malley; Daniel Q Naiman; Nancy A Jenkins; Neal G Copeland
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

8.  BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells.

Authors:  Yunyan Wu; Fuyuki Sato; Ujjal Kumar Bhawal; Takeshi Kawamoto; Katsumi Fujimoto; Mitsuhide Noshiro; Hiroko Seino; Satoko Morohashi; Yukio Kato; Hiroshi Kijima
Journal:  Biomed Res       Date:  2012-04       Impact factor: 1.203

9.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

10.  Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target.

Authors:  S A Hartsink-Segers; C M Zwaan; C Exalto; M W J Luijendijk; V S Calvert; E F Petricoin; W E Evans; D Reinhardt; V de Haas; M Hedtjärn; B R Hansen; T Koch; H N Caron; R Pieters; M L Den Boer
Journal:  Leukemia       Date:  2012-09-03       Impact factor: 11.528
View more
  2 in total

1.  BHLHE41 suppresses MCF-7 cell invasion via MAPK/JNK pathway.

Authors:  Di Zhang; Qin Zheng; Chen Wang; Na Zhao; Yang Liu; Enhua Wang
Journal:  J Cell Mol Med       Date:  2020-02-19       Impact factor: 5.310

2.  The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.

Authors:  Akihiko Numata; Hui Si Kwok; Akira Kawasaki; Jia Li; Qi-Ling Zhou; Jon Kerry; Touati Benoukraf; Deepak Bararia; Feng Li; Erica Ballabio; Marta Tapia; Aniruddha J Deshpande; Robert S Welner; Ruud Delwel; Henry Yang; Thomas A Milne; Reshma Taneja; Daniel G Tenen
Journal:  Nat Commun       Date:  2018-04-24       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.